Role of Annexin 7 (ANXA7) as a Tumor Suppressor and a Regulator of Drug Resistance in Thyroid Cancer. [PDF]
Bera A+7 more
europepmc +1 more source
Network pharmacology and molecular docking to explore the potential molecular mechanism of chlorogenic acid treatment of oral squamous cell carcinoma. [PDF]
Feng Z, Hao P, Yang Y, Xve X, Zhang J.
europepmc +1 more source
BRAF mutant PD-L1 positive metastatic musculoskeletal lesions from primary lung adenocarcinoma treated with combination vemurafenib and pembrolizumab: a case report. [PDF]
Ngelangel CA, Sy FF.
europepmc +1 more source
Preclinical Activity of the Type II RAF Inhibitor Tovorafenib in Tumor Models Harboring Either a BRAF Fusion or an NF1 Loss-of-Function Mutation. [PDF]
Rastogi S+5 more
europepmc +1 more source
Potential of epithelial membrane protein 3 as a novel therapeutic target for human breast cancer. [PDF]
Wang YW+9 more
europepmc +1 more source
BRAF Targeting Across Solid Tumors: Molecular Aspects and Clinical Applications. [PDF]
Mechahougui H+4 more
europepmc +1 more source
A BAG-1-inhibitory peptide, GO-Pep, suppresses c-Raf activity in cancer. [PDF]
Tatli O+12 more
europepmc +1 more source
A Childhood Langerhans Cell Histiocytosis With a Novel BRAFN486_T491delinsK Mutation: Good Response to Conventional Chemotherapy. [PDF]
Wan Z, Tang X, Gao J.
europepmc +1 more source
Inflammatory and Redox Blood Gene Expression Fingerprint of Severe Obstructive Sleep Apnoea in Patients With Mild Alzheimer's Disease. [PDF]
Romero-ElKhayat L+12 more
europepmc +1 more source